Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson
In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment setti...
17 Apr 202427min
Xylazine, heroin and drug markets with Caroline Copeland
In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entere...
9 Apr 202420min
Synthetic opioid production in Europe with Paul Griffiths
In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss orga...
4 Apr 202433min
Gambling advertising with Philip Newall
In this episode, Rob Calder talks to Dr Philip Newall about how the gambling industry frames the evidence on gambling advertising. Philip talks about researching the kinds of bets that are commonly ad...
8 Feb 202432min
Addiction and definitions with Robert West
In this episode Zoe Swithenbank talks to Professor Robert West about his work on ontologies within addictions. Robert begins by summarising the definitions and constructions that relate to addiction, ...
19 Des 202318min
Nitrous oxide, addiction and substance use disorder with Sammie Back and Emese Kroon
In this episode Dr Elle Wadsworth talks to Sammie Back and Emese Kroon about nitrous oxide. The discussion happened on 8 November 2023, on the day that possession of nitrous oxide became a Class C sub...
12 Des 202324min
Pregnancy and opioids with Jerry Cochran
In this episode Ben Scher talks to Professor Gerald (Jerry) Cochran about his article based on a randomized multisite pilot trial investigating the impact of Patient Navigation. Jerry begins by descri...
5 Des 202320min
